
Encompass Health Corp
NYSE:EHC

Intrinsic Value
The intrinsic value of one
EHC
stock under the Base Case scenario is
106.26
USD.
Compared to the current market price of 119.04 USD,
Encompass Health Corp
is
Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Encompass Health Corp
Loading...
Fundamental Analysis

Potential Medicare reimbursement cuts pose a heightened threat to Encompass Health’s core inpatient rehabilitation business, as over two thirds of revenue depends on government payment rates that can fluctuate unexpectedly.
Encompass Health’s position as one of the largest operators of inpatient rehabilitation hospitals gives it significant scale, enabling favorable contracting rates and cost efficiencies across its network.

Revenue & Expenses Breakdown
Encompass Health Corp
Balance Sheet Decomposition
Encompass Health Corp
Current Assets | 910.9m |
Cash & Short-Term Investments | 95.8m |
Receivables | 623.4m |
Other Current Assets | 191.7m |
Non-Current Assets | 5.7B |
PP&E | 3.9B |
Intangibles | 1.6B |
Other Non-Current Assets | 209.5m |
Free Cash Flow Analysis
Encompass Health Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Encompass Health Corp
Revenue
|
5.5B
USD
|
Cost of Revenue
|
-242.7m
USD
|
Gross Profit
|
5.3B
USD
|
Operating Expenses
|
-4.3B
USD
|
Operating Income
|
923.4m
USD
|
Other Expenses
|
-431.4m
USD
|
Net Income
|
492m
USD
|
EHC Profitability Score
Profitability Due Diligence
Encompass Health Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Score
Encompass Health Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
EHC Solvency Score
Solvency Due Diligence
Encompass Health Corp's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Score
Encompass Health Corp's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EHC Price Targets Summary
Encompass Health Corp
According to Wall Street analysts, the average 1-year price target for
EHC
is 134.21 USD
with a low forecast of 126.25 USD and a high forecast of 147 USD.
Dividends
Current shareholder yield for EHC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EHC
stock under the Base Case scenario is
106.26
USD.
Compared to the current market price of 119.04 USD,
Encompass Health Corp
is
Overvalued by 11%.